BIOMAT Database Logo BIOMAT Database Logo

[Drug activity of bleomycin against tubercle bacilli isolated from pulmonary tuberculous in-patients (author's transl)]. 1973

K Endo

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced

Related Publications

K Endo
[Host lipids in tuberculous infection. III. Long-chain fatty acids against tubercle bacilli (author's transl)].
March 1981, Kekkaku : [Tuberculosis],
K Endo
[Sulfa-resistant tubercle bacilli isolated from the sputum of tuberculous patients].
July 1966, Saishin igaku. Modern medicine,
K Endo
[Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
December 1976, Kekkaku : [Tuberculosis],
K Endo
[Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
January 1971, Bulletin of the Chest Disease Research Institute, Kyoto University,
K Endo
Pulmonary resections in patients harboring drug-resistant tubercle bacilli.
October 1961, The American review of respiratory disease,
K Endo
[Studies on thiacetazone resistance of tubercle bacilli. I. Thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
May 1971, Kekkaku : [Tuberculosis],
K Endo
[Detection of tubercle bacilli in patients with pulmonary tuberculosis by sampling of bronchial sputum (author's transl)].
December 1976, Kekkaku : [Tuberculosis],
K Endo
[Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
December 1981, Kekkaku : [Tuberculosis],
K Endo
[Clinical significance of precipitins against tubercle bacilli in blood serum of tuberculous patients].
May 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
K Endo
[Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
March 1974, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!